| Menopause |
1 |
1 |
| Sleep |
0 |
0.58 |
| Night Sweats |
0 |
0.52 |
| Vagina |
0 |
0.46 |
| Vaginal Discharge |
0 |
0.35 |
| Depression |
0 |
0.28 |
| Estrogen |
0 |
0.28 |
| Selective Estrogen Receptor Modulators |
0 |
0.27 |
| Mood Disorders |
0 |
0.2 |
| Exercise |
0 |
0.17 |
| Receptors |
0 |
0.17 |
| Stress |
0 |
0.17 |
| Coronary Artery Disease (CAD) |
0 |
0.16 |
| Cardiovascular Risk Management |
0 |
0.14 |
| Cognitive Behavioral Therapy |
0 |
0.14 |
| Heart |
0 |
0.14 |
| Postpartum Depression |
0 |
0.13 |
| Antidepressant drug |
0 |
0.12 |
| Anxiety |
0 |
0.12 |
| Bone |
0 |
0.12 |
| Dementia |
0 |
0.12 |
| Dyspareunia |
0 |
0.12 |
| Pain Management |
0 |
0.12 |
| Nonsteroidal Anti-Inflammatory Agents |
0 |
0.1 |
| Premenstrual Dysphoric Disorder |
0 |
0.1 |
| Brain |
0 |
0.09 |
| Premenstrual Syndrome |
0 |
0.09 |
| Weight Gain |
0 |
0.09 |
| Anxiety Disorder |
0 |
0.08 |
| Pregnancy |
0 |
0.08 |
| Sexual Dysfunction in Female |
0 |
0.08 |
| Weight Management |
0 |
0.08 |
| Cerebrovascular Accident |
0 |
0.07 |
| Migraine |
0 |
0.07 |
| Selective Serotonin-Reuptake Inhibitors |
0 |
0.07 |
| Sleep Disorders |
0 |
0.07 |
| Ablation |
0 |
0.06 |
| Chronic Pain |
0 |
0.06 |
| Cognition |
0 |
0.06 |
| Complementary and Alternative Medicine |
0 |
0.06 |
| Diet |
0 |
0.06 |
| Dysfunctional Uterine Bleeding |
0 |
0.06 |
| Gamma aminobutyric acid |
0 |
0.06 |
| Headache |
0 |
0.06 |
| Hypnosis |
0 |
0.06 |
| Memory |
0 |
0.06 |
| Moisturization |
0 |
0.06 |
| Oophorectomy |
0 |
0.06 |
| Pain |
0 |
0.06 |
| Postpartum |
0 |
0.06 |
| Progestin |
0 |
0.06 |
| Rapid Eye Movement |
0 |
0.06 |
| Sexual Health |
0 |
0.06 |
| Social Determinants of Health |
0 |
0.06 |
| Socioeconomics |
0 |
0.06 |
| Transdermal |
0 |
0.06 |
| Uterus |
0 |
0.06 |
| Vitamin |
0 |
0.06 |
| Breast |
0 |
0.05 |
| Thromboembolism |
0 |
0.05 |
| ADHD |
0 |
0.04 |
| Contraception |
0 |
0.04 |
| Adenomyosis |
0 |
0.03 |
| Adverse Effects |
0 |
0.03 |
| Alcohol Use |
0 |
0.03 |
| Anovulation |
0 |
0.03 |
| Antifibrinolytics |
0 |
0.03 |
| Aspirin |
0 |
0.03 |
| Biopsy |
0 |
0.03 |
| Blood |
0 |
0.03 |
| Body Mass Index |
0 |
0.03 |
| Burns |
0 |
0.03 |
| Calcium |
0 |
0.03 |
| Cancer |
0 |
0.03 |
| Cardiovascular disease |
0 |
0.03 |
| Chemotherapy |
0 |
0.03 |
| Clinical Research |
0 |
0.03 |
| Data Collection |
0 |
0.03 |
| Face |
0 |
0.03 |
| Fatigue |
0 |
0.03 |
| Fibroma |
0 |
0.03 |
| Food and Drug Administration (FDA) |
0 |
0.03 |
| Genetics |
0 |
0.03 |
| Genomic Medicine |
0 |
0.03 |
| Gland |
0 |
0.03 |
| Health Care Economics |
0 |
0.03 |
| Hormonal Therapy |
0 |
0.03 |
| Hypnotic Drug |
0 |
0.03 |
| Hysteroscopy |
0 |
0.03 |
| Incontinence |
0 |
0.03 |
| Insomnia |
0 |
0.03 |
| Laser |
0 |
0.03 |
| Meditation |
0 |
0.03 |
| Menstrual Migraine |
0 |
0.03 |
| Metabolism |
0 |
0.03 |
| Muscle |
0 |
0.03 |
| Neurotransmitters |
0 |
0.03 |
| Orbit |
0 |
0.03 |
| Perimenopausal Symptoms |
0 |
0.03 |
| Polyp |
0 |
0.03 |
| Psychosocial |
0 |
0.03 |
| Psychotherapy |
0 |
0.03 |
| Puberty |
0 |
0.03 |
| Quality of Life |
0 |
0.03 |
| Radiation Therapy |
0 |
0.03 |
| Sexual Dysfunction |
0 |
0.03 |
| Sexuality |
0 |
0.03 |
| Stigma |
0 |
0.03 |
| Tai Chi |
0 |
0.03 |
| Testosterone |
0 |
0.03 |
| Tryptamine |
0 |
0.03 |
| Ultrasonography |
0 |
0.03 |
| Urinary Tract Infection |
0 |
0.03 |
| Urinary Urgency |
0 |
0.03 |
| Venous Thromboembolism (VTE) |
0 |
0.03 |
| Weight Loss |
0 |
0.03 |
| Yoga |
0 |
0.03 |
| Healthcare and Medical Technology |
0 |
0.02 |
| Osteoarthritis |
0 |
0.02 |
| Osteoporosis |
0 |
0.02 |
| Patient Safety |
0 |
0.02 |
| Sleep Apnea |
0 |
0.02 |
| Wound Management |
0 |
0.02 |